Candidia Vulvovaginitis. acute vaginitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion Criteria: willingness to participate, reproductive age (between 18 years and premenopause age. Exclusion Criteria: pregnancy, breast feeding, using hormonal or immunosuppressive drugs, having sexually transmitted and autoimmune diseases or any other disease such as diabetes, allergy to Azole drugs, using antibiotics, antifungal compounds or vaginal drugs during two weeks prior to the study, suffering from recurrent vulvovaginitis (4 times or more during one year), using other supportive treatments like vaginal douch at the time of drug application, negative culture
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapeutic results of Candida vulvovaginitis. Timepoint: 10 days. Method of measurement: culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Fatemeh (PBUH) college of Nursing and Midwifery Shiraz University of Medical Sciences